Thrombosis |
From the Dorrance H. Hamilton Research Laboratories (M.-L.L., K.J.W.), Division of Endocrinology, Diabetes and Metabolic Diseases, and the Cardeza Foundation for Hematologic Research (M.P.R., P.C., S.E.M.), Division of Hematology, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pa.
Correspondence to Kevin Jon Williams or Ming-Lin Liu, Division of Endocrinology, Thomas Jefferson University, 1020 Locust Street, Suite 348, Philadelphia, PA 19107. E-mail K_Williams{at}mail.jci.tju.edu or Ming-lin.Liu@jefferson.edu
Objective Biologically significant amounts of two procoagulant molecules, phosphatidylserine (PS) and tissue factor (TF), are transported by monocyte/macrophage-derived microvesicles (MVs). Because cellular cholesterol accumulation is an important feature of atherosclerotic vascular disease, we now examined effects of cholesterol enrichment on MV release from human monocytes and macrophages.
Methods and Results Cholesterol enrichment of human THP-1 monocytes, alone or in combination with lipopolysaccharide (LPS), tripled their total MV generation, as quantified by flow cytometry based on particle size and PS exposure. The subset of these MVs that were also TF-positive was likewise increased by cellular cholesterol enrichment, and these TF-positive MVs exhibited a striking 10-fold increase in procoagulant activity. Moreover, cholesterol enrichment of primary human monocyte-derived macrophages also increased their total as well as TF-positive MV release, and these TF-positive MVs exhibited a similar 10-fold increase in procoagulant activity. To explore the mechanisms of enhanced MV release, we found that cholesterol enrichment of monocytes caused PS exposure on the cell surface by as early as 2 hours and genomic DNA fragmentation in a minority of cells by 20 hours. Addition of a caspase inhibitor at the beginning of these incubations blunted both cholesterol-induced apoptosis and MV release.
Conclusions Cholesterol enrichment of human monocyte/macrophages induces the generation of highly biologically active, PS-positive MVs, at least in part through induction of apoptosis. Cholesterol-induced monocyte/macrophage MVs, both TF-positive and TF-negative, may be novel contributors to atherothrombosis.
Cellular cholesterol accumulation is an important feature of atherosclerosis. In the current study, we found that cholesterol enrichment of human monocytes and macrophages substantially induced the generation of biologically-active microvesicles, including a subset that is tissue factorpositive and highly procoagulant. We conclude that cholesterol-induced monocyte/macrophage microvesicles may be novel contributors to atherothrombosis.
Key Words: macrophages microparticles tissue factor apoptosis atherosclerosis
This article has been cited by other articles:
![]() |
E. M. Egorina, M. A. Sovershaev, J. O. Olsen, and B. Osterud Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer Blood, February 1, 2008; 111(3): 1208 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lopez, B. Bermudez, Y. M. Pacheco, G. Lopez-Lluch, W. Moreda, J. Villar, R. Abia, and F. J. G. Muriana Dietary Oleic and Palmitic Acids Modulate the Ratio of Triacylglycerols to Cholesterol in Postprandial Triacylglycerol-Rich Lipoproteins in Men and Cell Viability and Cycling in Human Monocytes J. Nutr., September 1, 2007; 137(9): 1999 - 2005. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |